Sunil Healthcare Limited has intimated the Bombay Stock Exchange Limited and The Calcutta Stock Exchange Ltd about its upcoming 271st Meeting of the Board of Directors. The meeting is scheduled to be held on Friday, November 13, 2026 at the company's registered office at 38E/252A, Vijay Tower, 3rd Floor, Panchsheel Commercial Complex, Shahpur Jat, New Delhi-110049. The meeting will be conducted through video conferencing/audio visual connection, with this location deemed as the venue.
The primary agenda of the board meeting is to consider, approve and take on record the Un-audited Financial Results for the 2nd quarter and 1st half year ended on September 30, 2026 of the Financial Year 2026-27. Both standalone and consolidated financial results will be reviewed.
Additionally, the company confirms that the Trading Window under the provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 remains closed from October 01, 2026 till November 15, 2026 (both days inclusive). This closure was previously intimated on September 25, 2026.
The disclosure is made pursuant to Regulation 29 read with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The communication is signed by Satyendu Pattnaik, Company Secretary & Compliance Officer of Sunil Healthcare Limited.